CLEARPOINT NEURO INC (CLPT)
Health Care · neurosurgical navigation and stereotactic systems · NASDAQ
ClearPoint Neuro develops real-time imaging-guided stereotactic systems for minimally invasive brain surgery and intracranial drug delivery.
What CLEARPOINT NEURO INC does
ClearPoint Neuro designs and commercializes stereotactic neurosurgery navigation and therapeutic delivery systems used in brain surgery and interventional procedures. The company develops software and hardware platforms including the ClearPoint system, which provides real-time imaging guidance and drug delivery capabilities for minimally invasive brain procedures. It generates revenue through capital equipment sales, software licensing, biologics and drug delivery services, and related clinical support. The company also operates ClearPoint Advanced Laboratories, which provides specialized services in support of its therapeutic platforms.
Themes: ["neurosurgery navigation and guidance","minimally invasive brain surgery","intracranial drug delivery","stereotactic surgical systems","image-guided neurosurgery","medical device software platforms"]
Fundamentals
- Price$17.88 as of 2026-07-09 close
- Market cap$534M as of 2026-07-10
- 1-year return+47.0% as of 2026-07-09 close
- Net margin-71.6% as of 2026-07-10
- Gross margin+62.3% as of 2026-07-10
- ROE-141.0% as of 2026-07-10
- Debt / equity2.63 as of 2026-07-10
- Revenue growth (YoY)+26.0% as of 2026-07-10
- Revenue CAGR (3y)+21.6% SEC XBRL
- Beta1.23 as of 2026-07-10
Key risks (from latest filing)
["Company is unprofitable with negative net margin of -71.57%; substantial ongoing losses and capital needs create funding and cash depletion risk","Competition from established medical device manufacturers and alternative neurosurgery navigation technologies may limit market adoption and pricing power","Regulatory approval requirements and reimbursement policies for novel therapeutic delivery and imaging systems create commercialization and revenue uncertainty"]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.